Smart Metering
Search documents
Xylem(XYL) - 2025 Q3 - Earnings Call Presentation
2025-10-28 13:00
Financial Performance - Xylem's Q3 2025 reported revenue reached $2268 million, reflecting an 8% overall growth[6] - The organic growth for Q3 2025 was 7%[6] - Adjusted EBITDA margin for Q3 2025 hit a record 232%, a 200 bps year-over-year expansion[7, 11] - Adjusted EPS for Q3 2025 increased by 23%[7, 11] - The company is raising its full-year guidance to reflect robust year-to-date results and a positive outlook[8] Segment Performance - Water Infrastructure reported revenue of $656 million with 5% overall growth and 5% organic growth[6] - Applied Water reported revenue of $456 million with 2% overall growth and 1% organic growth[6] - Measurement and Control Solutions reported revenue of $522 million with 14% overall growth and 11% organic growth[6] - Water Solutions and Services reported revenue of $634 million with 10% overall growth and 10% organic growth[6] Guidance and Assumptions - The updated full-year revenue guidance is approximately $9 billion, representing a 5-6% total growth and 4-5% organic growth[19] - The adjusted EBITDA margin guidance for the full year is 220-223%, a 140-170 bps expansion[19] - The adjusted EPS guidance for the full year is $503-$508[19]
Here's Why Hold Strategy is Apt for Xylem Stock Right Now
ZACKS· 2025-06-04 16:01
Core Insights - Xylem Inc. (XYL) is experiencing strong momentum in its Measurement & Control Solutions segment, driven by high demand for advanced technology solutions such as smart metering [1] - The Water Infrastructure segment is benefiting from increased infrastructure projects in the U.S., particularly in the transport application business [1] - The Applied Water segment is recovering due to higher demand for building solutions applications [1] Financial Performance - As of the end of Q1 2025, Xylem's backlog reached $5.1 billion, supported by strong demand across utilities, industrial, and building solutions markets [2] - For 2025, Xylem anticipates revenues between $8.7 billion and $8.8 billion, reflecting a year-over-year increase of 1-2% [2] - In 2024, acquisitions contributed $786 million to the company's total revenues [4] Strategic Acquisitions - In December 2024, Xylem completed the acquisition of a majority stake in Idrica, enhancing its growth opportunities and market penetration [3] - The acquisition of Evoqua in May 2023 added advanced water and wastewater treatment capabilities to Xylem's portfolio, complementing its solutions across the water cycle [4] Shareholder Returns - In Q1 2025, Xylem paid dividends totaling $98 million and repurchased shares worth $12.9 million [5] - The company increased its dividend rate by 11% in February 2025 [5] Debt and Cost Management - Xylem exited Q1 2025 with long-term debt of $1.97 billion, while cash and cash equivalents stood at $1.06 billion [9] - The company faced rising operating costs, with a 15.1% year-over-year increase in cost of revenues in 2024, and a 1.6% increase in Q1 2025 [9]
Silicon Labs Revenue Beats Estimates, Analysts Highlight Inventory Recovery
Benzinga· 2025-05-14 19:14
Core Insights - Silicon Laboratories, Inc. reported first-quarter revenues of $178 million, exceeding market expectations, with significant growth in both Industrial & Commercial and Home & Life segments [1] - The company reaffirmed its full-year outlook, projecting FY25 revenue of $785 million, with analysts anticipating upward revisions to consensus estimates following positive results [2][3] Financial Performance - Industrial & Commercial revenue reached $96 million, a 47% year-over-year increase, while Home & Life revenue was $82 million, reflecting a 99% year-over-year growth [1] - Analysts project mid-single-digit quarter-over-quarter growth for the third and fourth quarters, estimating sales of $203 million and $216 million respectively [2] Analyst Expectations - Benchmark analyst Cody Acree expects modest upward revisions to consensus estimates and maintains a Buy rating with a price target of $160 [5] - Needham analyst N. Quinn Bolton also reiterated a Buy rating, projecting a price target of $150 and forecasting over 20% year-over-year revenue growth for FY25, with a more aggressive estimate of 33% growth [3][5] Market Trends - The company’s end markets are recovering from cyclical downturns, with inventory levels returning to typical ranges, indicating a positive trend in customer and channel inventory management [2][4] - Growth in the second half of FY25 is expected to be driven by design wins in smart metering, continuous glucose monitors, and electronic shelf labels [4]